Oligoclonality and innate-like features in the TCR repertoire of type II NKT cells reactive to a β-linked self-glycolipid
- 15 June 2010
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (24) , 10984-10989
- https://doi.org/10.1073/pnas.1000576107
Abstract
TCR-mediated recognition of beta-linked self-glycolipids bound to CD1d is poorly understood. Here, we have characterized the TCR repertoire of a CD1d-restricted type II NKT cell subset reactive to sulfatide involved in the regulation of autoimmunity and antitumor immunity. The sulfatide/CD1d-tetramer(+) cells isolated from naïve mice show an oligoclonal TCR repertoire with predominant usage of the Valpha3/Valpha1-Jalpha7/Jalpha9 and Vbeta8.1/Vbeta3.1-Jbeta2.7 gene segments. The CDR3 regions of both the alpha- and beta-chains are encoded by either germline or nongermline gene segments of limited lengths containing several conserved residues. Presence of dominant clonotypes with limited TCR gene usage for both TCR alpha- and beta-chains in type II NKT cells reflects specific antigen recognition not found in the type I NKT cells but similar to the MHC-restricted T cells. Although potential CD1d-binding tyrosine residues in the CDR2beta region are conserved between most type I and type II NKT TCRs, CDR 1alpha and 3alpha regions differ significantly between the two subsets. Collectively, the TCR repertoire of sulfatide-reactive type II NKT cells exhibits features of both antigen-specific conventional T cells and innate-like cells, and these findings provide important clues to the recognition of beta-linked glycolipids by CD1d-restricted T cells in general.Keywords
This publication has 42 references indexed in Scilit:
- Differential Recognition of CD1d-α-Galactosyl Ceramide by the Vβ8.2 and Vβ7 Semi-invariant NKT T Cell ReceptorsImmunity, 2009
- T Cell Receptor CDR2β and CDR3β Loops Collaborate Functionally to Shape the iNKT Cell RepertoireImmunity, 2009
- Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancerBlood, 2008
- Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphomaBlood, 2008
- Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: Implications for posttransplant survivalExperimental Hematology, 2008
- A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCRThe Journal of Experimental Medicine, 2008
- Type II NKT cell–mediated anergy induction in type I NKT cells prevents inflammatory liver diseaseJournal of Clinical Investigation, 2007
- Invariant and Noninvariant Natural Killer T Cells Exert Opposite Regulatory Functions on the Immune Response during Murine SchistosomiasisInfection and Immunity, 2007
- Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiencyProceedings of the National Academy of Sciences, 2007
- Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammalsProceedings of the National Academy of Sciences, 2007